Your browser doesn't support javascript.
loading
Dual-target IL-12-containing nanoparticles enhance T cell functions for cancer immunotherapy.
Li, Jieyu; Lin, Wansong; Chen, Huijing; Xu, Zhiping; Ye, Yunbin; Chen, Mingshui.
Afiliación
  • Li J; Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, China; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian 350014, China.
  • Lin W; Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, China; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian 350014, China; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, Fujian 3
  • Chen H; Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, China; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian 350014, China.
  • Xu Z; Australian Institute for Bioengineering and Nanotechnology (Building 75), The University of Queensland, Cooper Rd., St Lucia, Brisbane, QLD 4072, Australia.
  • Ye Y; Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, China; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian 350014, China. Electronic address: zjyunbin@sina.com.
  • Chen M; Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, China; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian 350014, China. Electronic address: 838195033@qq.com.
Cell Immunol ; 349: 104042, 2020 03.
Article en En | MEDLINE | ID: mdl-32061376

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfocitos T Citotóxicos / Interleucina-12 / Linfocitos T CD8-positivos / Nanocápsulas / Inmunoterapia Límite: Humans Idioma: En Revista: Cell Immunol Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfocitos T Citotóxicos / Interleucina-12 / Linfocitos T CD8-positivos / Nanocápsulas / Inmunoterapia Límite: Humans Idioma: En Revista: Cell Immunol Año: 2020 Tipo del documento: Article País de afiliación: China